Oxford, UK - Vaccitech Ltd announces that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The vaccine was...
Month: December 2020
First peer-reviewed results of Phase 3 human trials of Oxford vaccine demonstrate efficacy
Oxford, UK - Vaccitech’s scientific founders at University of Oxford and Astrazeneca announce the first peer-reviewed publication of Phase 3 data from studies of a vaccine against the coronavirus in the Lancet. The vaccine, ChAdOx1 nCoV-19, also known as AZD1222, was...
Vaccitech Chief Scientific Officer Dr. Thomas Evans on COVID-19 vaccination
In an interview with Sky News, Vaccitech Chief Scientific Officer, Dr. Thomas Evans, discusses the regulatory and public health aspects of Emergency Use Authorisation of COVID-19 vaccines. The interview aired on the 2nd of December 2020.
Vaccitech Co-Founder Professor Adrian Hill on Developing a Covid-19 Vaccine
Following the news that AstraZeneca, the University of Oxford, and Vaccitech's vaccine for COVID-19 is highly effective and safe, Vaccitech co-founder Professor Adrian Hill talked to Tom Hulme, General Partner at Vaccitech shareholder GV, Vidu Shanmugarajah, Partner...